Bone Biologics Corp
BBLG· Nasdaq
Filed Jan 30, 2012 · 10-K · 91 days after period end · 0001387131-12-000151
derived · Computed from the longer spans the company filed.
| Metric | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|
| Net Income | -$1.72K | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Oct 31, 2011 · filed Jan 30, 2012 · 91 d after period end